Personalized Medicine in the Information Age: Myriad's De Facto Monopoly on Breast Cancer Research.
作者信息
Oliver Angela M
机构信息
SMU Dedman School of Law.
出版信息
SMU Law Rev. 2015;68(2):537-66.
PMID:30028113
Abstract
摘要
相似文献
1
2
Patents on breast cancer genes are illegal and stymie research, say scientists.科学家们表示，乳腺癌基因专利是非法的，并且阻碍了研究。
BMJ. 2009 Nov 17;339:b4899. doi: 10.1136/bmj.b4899.
3
Myriad Genetics embroiled in breast-cancer data fight - again.Myriad Genetics再次卷入乳腺癌数据之争。
Nature. 2016 May 26;533(7604):449. doi: 10.1038/nature.2016.19953.
4
Supreme Court ruling broadens BRCA testing options.最高法院裁决扩大了BRCA检测选项。
J Natl Cancer Inst. 2013 Nov 20;105(22):1671-2. doi: 10.1093/jnci/djt342. Epub 2013 Nov 6.
5
Cancer-gene data sharing boosted.癌症基因数据共享得到加强。
Nature. 2014 Jun 12;510(7504):198. doi: 10.1038/510198a.
6
Supreme Court will rule on whether patents for BRAC1 and BRAC2 genes are valid.最高法院将就乳腺癌1号基因（BRAC1）和乳腺癌2号基因（BRAC2）的专利是否有效做出裁决。
BMJ. 2012 Dec 5;345:e8266. doi: 10.1136/bmj.e8266.
7
Gene patenting--the Supreme Court finally speaks.基因专利——最高法院终于表态了。
N Engl J Med. 2013 Aug 29;369(9):869-75. doi: 10.1056/NEJMhle1308199. Epub 2013 Jul 10.
8
Direct to confusion: lessons learned from marketing BRCA testing.直接导致混乱：从BRCA检测营销中吸取的教训。
Am J Bioeth. 2008 Jun;8(6):5-8. doi: 10.1080/15265160802248179.
9
[The Supreme Court free genes - economic and legal justifications - impacts on innovation and the healthcare offer].[最高法院的自由基因——经济和法律依据——对创新及医疗服务的影响]
Med Sci (Paris). 2015 Feb;31(2):209-13. doi: 10.1051/medsci/20153102019. Epub 2015 Mar 4.
10
Malta provides loophole for breast-cancer screen.
Nature. 2002 Oct 24;419(6909):767. doi: 10.1038/419767b.
Zotero 插件